Treviamet Tablets 50/1000mg (35’s) provide a powerful combination therapy for managing type 2 diabetes. Each tablet contains:
- Sitagliptin (50mg): A DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar by increasing insulin release and reducing glucose production.
- Metformin (1000mg): A well-known biguanide that decreases glucose production in the liver and improves insulin sensitivity in the body.
This dual-action treatment is ideal for individuals who require both sitagliptin and metformin to achieve optimal blood sugar control, along with lifestyle changes such as diet and exercise.
Key Benefits:
- Dual-Action Control: Combines two effective medications for comprehensive blood sugar management.
- Improves Insulin Sensitivity: Helps the body use insulin more effectively and reduces insulin resistance.
- Convenient Formulation: Combines both medications in one tablet for ease of use and better adherence to the treatment plan.
Dosage and Administration:
- Recommended Dose: One tablet twice daily with meals to help reduce gastrointestinal discomfort.
- Administration: Always follow your healthcare provider’s specific dosage instructions.
Precautions:
- Kidney and Liver Function: Not recommended for individuals with severe kidney or liver impairment.
- Lactic Acidosis Risk: Metformin may cause lactic acidosis in rare cases; monitor for symptoms such as muscle pain or unusual tiredness.
- Pregnancy and Breastfeeding: Use only under the guidance of your healthcare provider during pregnancy or breastfeeding.
Possible Side Effects:
- Common: Diarrhea, nausea, stomach upset, or mild hypoglycemia.
- Rare: Allergic reactions, pancreatitis, or lactic acidosis; seek immediate medical attention if these occur.
Reviews
There are no reviews yet.